NCI | Technology Transfer

Immortalized T-Lymphocyte Cell Line for Testing HTLV-III Inactivation

Read more about Immortalized T-Lymphocyte Cell Line for Testing HTLV-III Inactivation

US Patent 4,704,357
Filed on 1985-09-30

METHOD OF PREPARING 1,2-DIAMINOCYCLOHEXANE TETRACHLORO PLATINUM (4) ISOMERS

Read more about METHOD OF PREPARING 1,2-DIAMINOCYCLOHEXANE TETRACHLORO PLATINUM (4) ISOMERS

US Patent 4,658,047
Filed on 1985-09-27

TRANS-ACTIVATING FACTOR OF HTLV-III/LAV

Read more about TRANS-ACTIVATING FACTOR OF HTLV-III/LAV

US Application 06/780,925
Filed on 1985-09-27

HTLV-III/LAV Synthetic peptide

Read more about HTLV-III/LAV Synthetic peptide

US Application 06/779,431
Filed on 1985-09-24

Target Specific Cross-Linked Heteroantibodies

Read more about Target Specific Cross-Linked Heteroantibodies

US Patent 4,676,980
Filed on 1985-09-23

A METHOD AND KIT FOR DETECTING HUMAN EXPOSURE TO GENOTOXIC AGENTS

Read more about A METHOD AND KIT FOR DETECTING HUMAN EXPOSURE TO GENOTOXIC AGENTS

US Patent 4,794,074
Filed on 1985-09-23

ANTIVIRAL COMPOSITIONS AND METHODS

Read more about ANTIVIRAL COMPOSITIONS AND METHODS

US Application 06/769,017
Filed on 1985-08-26

INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-...

Read more about INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYINOSINE, 2',3'-...

US Application 06/769,016
Filed on 1985-08-26

ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS

Read more about ADOPTIVE IMMUNOTHERAPY AS A TREATMENT MODALITY IN HUMANS

US Patent 4,690,915
Filed on 1985-08-08

Method of Producing Improved Immune Response

Read more about Method of Producing Improved Immune Response

US Application 06/763,218
Filed on 1985-08-07

Subscribe to NCI